Molecular mechanism of doxorubicin-induced cardiomyopathy–An update

K Renu, VG Abilash, TP PB, S Arunachalam - European journal of …, 2018 - Elsevier
Doxorubicin is utilized for anti-neoplastic treatment for several decades. The utility of this
drug is limited due to its side effects. Generally, doxorubicin toxicity is originated from the …

Doxorubicin‐induced cardiotoxicity: from bioenergetic failure and cell death to cardiomyopathy

FS Carvalho, A Burgeiro, R Garcia… - Medicinal research …, 2014 - Wiley Online Library
Doxorubicin (DOX) is an anticancer anthracycline that presents a dose‐dependent and
cumulative cardiotoxicity as one of the most serious side effects. Several hypotheses have …

Mitochondrial outer membrane protein FUNDC2 promotes ferroptosis and contributes to doxorubicin-induced cardiomyopathy

N Ta, C Qu, H Wu, D Zhang, T Sun… - Proceedings of the …, 2022 - National Acad Sciences
Ferroptosis is an iron-dependent programmed necrosis characterized by glutathione (GSH)
depletion and lipid peroxidation (LPO). Armed with both the pro-and antiferroptosis …

Doxorubicin: the good, the bad and the ugly effect

C Carvalho, RX Santos, S Cardoso… - Current medicinal …, 2009 - ingentaconnect.com
The anthracycline doxorubicin (DOX) is widely used in chemotherapy due to its efficacy in
fighting a wide range of cancers such as carcinomas, sarcomas and hematological cancers …

Updates in anthracycline-mediated cardiotoxicity

CG Nebigil, L Désaubry - Frontiers in Pharmacology, 2018 - frontiersin.org
Cardiotoxicity is one of the main adverse effects of chemotheraphy, affecting the completion
of cancer therapies and the short-and long-term quality of life. Anthracyclines are currently …

Protective effects of curcumin against doxorubicin-induced toxicity and resistance: A review

M Mohajeri, A Sahebkar - Critical reviews in oncology/hematology, 2018 - Elsevier
Doxorubicin (DOX)-induced toxicity and resistance are major obstacles in chemotherapeutic
approaches. Despite effective in the treatment of numerous malignancies, some clinicians …

Metabolic aspects of anthracycline cardiotoxicity

M Russo, A Della Sala, CG Tocchetti… - … treatment options in …, 2021 - Springer
Opinion statement Heart failure (HF) is increasingly recognized as the major complication of
chemotherapy regimens. Despite the development of modern targeted therapies such as …

Astaxanthin ameliorates doxorubicin-induced cognitive impairment (chemobrain) in experimental rat model: impact on oxidative, inflammatory, and apoptotic …

SE El-Agamy, AK Abdel-Aziz, S Wahdan, A Esmat… - Molecular …, 2018 - Springer
Chemobrain refers to a common sequelae experienced by 15–80% of cancer patients
exposed to chemotherapeutics. The antineoplastic agent doxorubicin (DOX) has been …

An update on the mechanisms related to cell death and toxicity of doxorubicin and the protective role of nutrients

A Varela-López, M Battino, MD Navarro-Hortal… - Food and Chemical …, 2019 - Elsevier
Doxorubicin (DOX), is a very effective chemotherapeutic agent against cancer whose clinical
use is limited by toxicity. Different strategies have been proposed to attenuate toxicity …

Mechanisms of chemotherapy-induced behavioral toxicities

EG Vichaya, GS Chiu, K Krukowski… - Frontiers in …, 2015 - frontiersin.org
While chemotherapeutic agents have yielded relative success in the treatment of cancer,
patients are often plagued with unwanted and even debilitating side-effects from the …